Hi ma420,
I am happy to be corrected, I recall Alan stating at the AGM, that he considered it a failure if Cu 6 (he may have said Bio Techs in general) don't get taken out by big Pharma.
IMHO the play is release compelling results so that Big Pharma companies don't want to come second in the CU 6 acquisition.
The real money (but not all of it) is in the Theranostic play as they will have IP protection for 14 years which isn't the case in Diagnostics due to PASS THROUGH 3 Year Scheme for diagnostic billing in th US. (TLX's runs out Dec 2024).
Will be interesting to see who the replacement director is, Believe it will be someone with expertise in M&A.(pure Guess)
Hi ma420,I am happy to be corrected, I recall Alan stating at...
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.65 |
Change
0.380(11.6%) |
Mkt cap ! $1.134B | |||
| Open | High | Low | Value | Volume |
| $3.30 | $3.75 | $3.29 | $15.67M | 4.533M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6405 | $3.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.65 | 13893 | 3 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$3.65 |
Change
0.380 ( 11.9 %) |
||||
| Open | High | Low | Volume | ||
| $3.29 | $3.76 | $3.29 | 345059 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| CU6 (ASX) Chart |